Formation of prostaglandins E2 and D2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase - PubMed (original) (raw)
. 2003 Aug 1;278(31):28479-89.
doi: 10.1074/jbc.M303984200. Epub 2003 May 13.
William E Zackert, Justin J Hasford, Michael E Danekis, Ginger L Milne, Catha Remmert, Jeff Reese, Huiyong Yin, Hsin-Hsiung Tai, Sudhansu K Dey, Ned A Porter, Jason D Morrow
Affiliations
- PMID: 12746435
- DOI: 10.1074/jbc.M303984200
Free article
Formation of prostaglandins E2 and D2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase
Ling Gao et al. J Biol Chem. 2003.
Free article
Abstract
It has heretofore been assumed that the cyclooxygenases (COXs) are solely responsible for peostaglandin (PG) synthesis in vivo. An important structural feature of PGH2 formed by COX is the trans-configuration of side chains relative to the prostane ring. Previously, we reported that a series of PG-like compounds termed isoprostanes (IsoPs) are formed in vivo in humans from the free radical-catalyzed peroxidation of arachidonate independent of COX. A major difference between these compounds and PGs is that IsoPs are formed from endoperoxide intermediates, the vast majority of which contain side chains that are cis relative to the prostane ring. In addition, unlike the formation of eicosanoids from COX, IsoPs are formed as racemic mixtures because they are generated nonenzymatically. IsoPs containing E- and D-type prostane rings (E2/D2-IsoPs) are one class of IsoPs formed, and we have reported previously that one of the major IsoPs generated is 15-E2t-IsoP (8-iso-PGE2). Unlike PGE2, 15-E2t-IsoP is significantly more unstable in buffered solutions in vitro and undergoes epimerization to PGE2. Analogously, the D-ring IsoP (15-D2c-IsoP) would be predicted to rearrange to PGD2. We now report that compounds identical in all respects to PGE2 and PGD2 and their respective enantiomers are generated in vivo via the IsoP pathway, presumably by epimerization of racemic 15-E2t-IsoP and 15-D2c-IsoP, respectively. Racemic PGE2 and PGD2 were present esterified in phospholipids derived from liver tissue from rats exposed to oxidant stress at levels of 24 +/- 16 and 37 +/- 12 ng/g of tissue, respectively. In addition, racemic PGs, particularly PGD2, were present unesterified in urine from normal animals and humans and represented up to 10% of the total PG detected. Levels of racemic PGD2 increased 35-fold after treatment of rats with carbon tetrachloride to induce oxidant stress. In this setting, PGD2 and its enantiomer generated by the IsoP pathway represented approximately 30% of the total PGD2 present in urine. These findings strongly support the contention that a second pathway exists for the formation of bioactive PGs in vivo that is independent of COX.
Similar articles
- Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione.
Morrow JD, Roberts LJ, Daniel VC, Awad JA, Mirochnitchenko O, Swift LL, Burk RF. Morrow JD, et al. Arch Biochem Biophys. 1998 May 1;353(1):160-71. doi: 10.1006/abbi.1998.0645. Arch Biochem Biophys. 1998. PMID: 9578611 - Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humans.
Yin H, Gao L, Tai HH, Murphey LJ, Porter NA, Morrow JD. Yin H, et al. J Biol Chem. 2007 Jan 5;282(1):329-36. doi: 10.1074/jbc.M608975200. Epub 2006 Nov 15. J Biol Chem. 2007. PMID: 17107953 - Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo.
Morrow JD, Awad JA, Wu A, Zackert WE, Daniel VC, Roberts LJ 2nd. Morrow JD, et al. J Biol Chem. 1996 Sep 20;271(38):23185-90. doi: 10.1074/jbc.271.38.23185. J Biol Chem. 1996. PMID: 8798513 - The cyclopentenone (A2/J2) isoprostanes--unique, highly reactive products of arachidonate peroxidation.
Milne GL, Musiek ES, Morrow JD. Milne GL, et al. Antioxid Redox Signal. 2005 Jan-Feb;7(1-2):210-20. doi: 10.1089/ars.2005.7.210. Antioxid Redox Signal. 2005. PMID: 15650409 Review. - The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress.
Morrow JD. Morrow JD. Curr Pharm Des. 2006;12(8):895-902. doi: 10.2174/138161206776055985. Curr Pharm Des. 2006. PMID: 16533158 Review.
Cited by
- Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress.
Andersson DA, Gentry C, Moss S, Bevan S. Andersson DA, et al. J Neurosci. 2008 Mar 5;28(10):2485-94. doi: 10.1523/JNEUROSCI.5369-07.2008. J Neurosci. 2008. PMID: 18322093 Free PMC article. - Isoprostanes.
Roberts LJ 2nd, Milne GL. Roberts LJ 2nd, et al. J Lipid Res. 2009 Apr;50 Suppl(Suppl):S219-23. doi: 10.1194/jlr.R800037-JLR200. Epub 2008 Oct 28. J Lipid Res. 2009. PMID: 18957694 Free PMC article. - Women and smokers have elevated urinary F(2)-isoprostane metabolites: a novel extraction and LC-MS methodology.
Taylor AW, Bruno RS, Traber MG. Taylor AW, et al. Lipids. 2008 Oct;43(10):925-36. doi: 10.1007/s11745-008-3222-1. Epub 2008 Aug 27. Lipids. 2008. PMID: 18751751 Free PMC article. - IL-9 protects against bleomycin-induced lung injury: involvement of prostaglandins.
Arras M, Louahed J, Heilier JF, Delos M, Brombacher F, Renauld JC, Lison D, Huaux F. Arras M, et al. Am J Pathol. 2005 Jan;166(1):107-15. doi: 10.1016/S0002-9440(10)62236-5. Am J Pathol. 2005. PMID: 15632004 Free PMC article. - Signature profile of cyclooxygenase-independent F2 series prostaglandins in C. elegans and their role in sperm motility.
Tiwary E, Hu M, Miller MA, Prasain JK. Tiwary E, et al. Sci Rep. 2019 Aug 13;9(1):11750. doi: 10.1038/s41598-019-48062-y. Sci Rep. 2019. PMID: 31409838 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- CA77839/CA/NCI NIH HHS/United States
- DK48831/DK/NIDDK NIH HHS/United States
- GM42056/GM/NIGMS NIH HHS/United States
- HD12304/HD/NICHD NIH HHS/United States
- HL46296/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources